Bio Medica Laboratories Limited is a pharmaceutical manufacturing company engaged in the production of formulations and healthcare products. The company earns revenue mainly through manufacturing and supplying pharmaceutical products, including injectables, tablets, capsules, dry syrups, ointments, and OTC products for domestic and export markets. Its products are used by hospitals, healthcare institutions, pharmacies, and pharmaceutical companies. The company also focuses on contract manufacturing and formulation development for third-party clients.

Bio Medica Laboratories an Book Built Issue, amounting to ₹ 52.43 Crore,consisting an fresh issue of 0.34 crore shares aggregating to ₹47.19 crore and offer for sale of  0.04 crore shares aggregating to ₹5.24 crore The subscription period for the Bio Medica Laboratories IPO opens on May 21, 2026, and close on May 25, 2026. The allotment is expected to be finalized on or about May 26, 2026, Tuesday, and the shares will be listed on the NSE SME with a tentative listing date set on or about Friday, May 29, 2026.

The Share Price Band of Bio Medica Laboratories IPO is set at ₹132 to ₹139 per share  per equity share. The Market Capitalisation of the Bio Medica Laboratories at IPO price of ₹139  per equity share will be ₹174.79 Cr. The lot size of the IPO is 1,000 shares. Retail investors are required to invest a minimum of ₹ 278,000, 2 lots ( 2,000 Shares), while the minimum investment for High-Net-Worth Individuals (HNIs) is 3 lots ( 3,000 shares), amounting to ₹ 417,000.

NARNOLIA FINANCIAL SERVICES LIMITED, the book running lead manager of the Bio Medica Laboratories Ltd. while SKYLINE FINANCIAL SERVICES PRIVATE LIMITED is the registrar for the issue.The Market Maker of the company is Prabhat Financial Services Ltd.

Bio Medica Laboratories Limited IPO GMP Today
The Grey Market Premium of Bio Medica Laboratories IPO is expected to be ₹0 based on the financial performance of the company. No real trading is done on the basis of Grey Market Premium that's why no real discovery of price can be done before the listing of shares on the stock exchange. The Grey Market Premium totally depends upon the Demand and Supply of the shares of the company in unorganized manner which is not recommended. The Grey Market Premium is mentioned for educational and informational purposes only.

Bio Medica Laboratories Limited IPO Live Subscription Status Today: Real-Time Update
The subscription period for the Bio Medica Laboratories IPO opens on May 21, 2026

Bio Medica Laboratories Limited IPO Allotment Date - Step by Step Guide to Check Allotment Status Online
Bio Medica Laboratories IPO allotment date is May 26, 2026, Tuesday, Bio Medica Laboratories IPO Allotment will be out on May 26, 2026, Tuesday, and will be live on Registrar Website from the allotment date.
SKYLINE FINANCIAL SERVICES PRIVATE LIMITED IPO Allotment Status here. Here's how you can check the allotment status:
- Navigate to the IPO allotment status page.
- Select Bio Medica Laboratories IPO from the dropdown list of IPO
- Enter your application number, PAN, or DP Client ID
- Submit the details to check your allotment status.
By following either of these methods, investors can quickly determine their allotment status and proceed accordingly with their investments.

Objectives of Bio Medica Laboratories Limited IPO
Bio Medica Laboratories to utilise the Net Proceeds towards the following objects:
1. ₹650.00 Lakhs is required for Repayment of Loan
2. ₹2,850.00 Lakhs is required for Enhancement of its existing production capabilities by setting up of new manufacturing facility at the existing premises
3. General Corporate Purposes.

Refer to Bio Medica Laboratories Limited RHP for more details about the Company.